查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2084900

人工器官庫市場：2026-2032年全球市場預測（按器官類型、技術、材料類型、應用和最終用戶分類）

Artificial Organ Bank Market by Organ Type, Technology, Material Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，人工器官庫市場規模將達到 199.2 億美元，複合年成長率為 7.25%。

主要市場統計數據
基準年 2025 122億美元
預計年份：2026年 130.4億美元
預測年份 2032 199.2億美元
複合年成長率 (%) 7.25%

人工器官庫執行摘要

人工器官庫正逐漸成為一種策略性醫療基礎設施模式，它將人工器官、生物假體器官、植入式醫療設備器材、人工組織、器官保存系統和數位匹配平台連接起來，從而建立更可靠的器官移植和替代途徑。這種需求源自於可衡量的公共衛生挑戰。根據美國衛生資源和服務部 (HRSA) 統計，全美有超過 10 萬人正在等待器官移植，每天約有 17 人在等待器官的過程中死亡。人口老化、糖尿病、心血管疾病、肝病、呼吸衰竭和慢性腎臟病因素加劇了全球類似的器官移植壓力。

人工器官庫格局的變革性變化

人工器官庫的格局正從實驗性創新轉變為一體化的臨床基礎設施。生物材料、去細胞支架、幹細胞衍生組織、晶片器官檢驗、免疫調節和積層製造技術的進步，正在加速從被動儲存到永續、可監測且品管的器官替代生態系統的過渡。同時，低溫和常溫機械灌注技術正在延長捐贈器官的評估期，並建立與未來人工和生物假體器官庫存直接相關的品質控制方案。

人工智慧對人工器官庫的累積影響

人工智慧正透過改善患者與設備的匹配、移植優先排序、庫存規劃、移植後監測、品質保證和不利事件檢測，對整個人工器官庫系統產生累積影響。儘管美國食品藥物管理局（FDA）已批准數百種人工智慧驅動的醫療設備應用於醫療保健領域，表明軟體主導的臨床決策支援正獲得監管支持，但人工器官的應用仍需嚴格的檢驗、偏差監測、網路安全措施和人工臨床監督。

關於引進人工器官庫的關鍵區域性見解

在亞太地區，中國、日本、印度、韓國、澳洲和東南亞國協正蓬勃發展，這得益於龐大的患者群體、慢性病盛行率的上升、移植中心的不斷擴建以及政府對生物技術的支持。該地區在電子、機器人、生物材料和再生醫學方面也擁有強大的技術實力，但經濟負擔、保險報銷差異和醫療資源取得不平等仍然是重要的障礙。北美仍然是創新最成熟的中心，這得益於其先進的移植網路、完善的器官捐贈系統、FDA核准流程、大學附屬醫療中心、健全的保險報銷機制以及對醫療技術的積極資金籌措。歐洲則受益於協調的移植組織、強大的生物醫學工程、完善的組織和細胞管治以及歐盟在可追溯性、安全性和生命週期監測方面取得的監管進展。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

東協（包括印尼、泰國、馬來西亞、新加坡、越南和菲律賓）憑藉其不斷擴展的專科醫療、移植服務和私立醫院網路，蘊藏著巨大的市場機會。然而，報銷體系的多樣性和移植基礎設施的不平衡，使得在地化市場准入模式勢在必行。海灣合作理事會國家（GCC）由於醫療費用支出高、糖尿病和心血管疾病負擔沉重、政府主導的醫院現代化以及對醫療自給自足能力的日益重視，有望更廣泛地採用高階植入器官和先進植入物。在歐盟，市場規模透過安全標準的統一、醫療設備法規（MDR）的遵守、跨境研究資助、組織和細胞管治以及資料保護要求得到保障，這些措施正在促進可追溯且基於證據的人工器官庫模式的發展。

關鍵國家在優先發展人工器官庫市場的洞察

美國憑藉其世界領先的器官移植等待名單數據透明度、成熟的FDA監管框架、先進的器官捐贈網路以及積極推廣心臟和腎臟輔助設備以及糖尿病管理技術，成為器官移植需求的主要來源。加拿大則強調規範化的准入、公共保險報銷以及專業的移植中心。同時，墨西哥和巴西的需求也不斷成長，這得益於醫院容量的擴大和慢性病管理計畫的推進。巴西尤其重要，因為大規模的公共移植系統和完善的全國性器官捐贈體系。在拉丁美洲，這些各國的具體趨勢表明，人工器官庫的建立應首先在先進的三級醫療機構啟動，然後透過公私合作的轉診網路逐步擴展。

為人工器官庫管理者提供的實用建議

產業領導者應優先考慮結合人工器官、保存平台、數位登記系統和人工智慧監測的、經過臨床檢驗的產品系列，而非單一的醫療設備。商業性成功取決於能否證明其在提高生存率、改善生活品質、增強生物相容性、有效控制感染、提升器械耐用性、確保公平獲取以及降低整體醫療成本等方面具有優勢。

基於證據的市場資訊調查方法

本執行摘要採用結構化的二手研究方法編寫，該方法檢驗了來自衛生部門、移植登記處、監管機構、同行評審期刊、臨床試驗庫、專利調查方法、公共資訊和全球公認的健康資訊來源的公開數據。主要資訊來源包括美國衛生資源與服務管理局/器官移植網路 (HRSA/OPTN)、世界衛生組織 (WHO) 附屬移植觀察站、美國食品藥物管理局 (FDA)醫療設備資料庫、歐洲藥品管理局 (EMA) 和歐盟監管出版刊物、美國國立衛生研究院 (NIH) 資源、經合組織 (OECD) 健康指標和各國移植指標和各國移植指標。

結論：人工器官庫作為下一代醫療基礎設施

人工器官庫市場正朝著平台化的未來發展，屆時人工器官、先進的保存技術、人工智慧驅動的匹配系統以及真實世界的性能數據將協同運作，以解決移植器官短缺的問題。最有前景的發展路徑將是開發臨床可靠的技術，這些技術既要滿足嚴格的安全性、耐用性、網路安全性和報銷標準，又要能夠彌補可衡量的供給能力缺口。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：人工器官庫市場：依器官類型分類

  • 心
  • 腸子
  • 腎
  • 肝
  • 肺
  • 胰臟

第8章：人工器官庫市場：依技術分類

  • 3D生物列印
    • 擠出式生物列印
    • 噴墨列印和生物列印
    • 雷射輔助生物列印
  • 細胞培養
  • 去細胞化
  • 基於支架的技術
    • 陶瓷支架
    • 天然聚合物支架
    • 合成聚合物支架

第9章：人工器官庫市場：依材料類型分類

  • 生物來源
    • 同種異體移植
    • 本土種植
  • 合成
    • 複合材料
    • 聚合物

第10章：人工器官庫市場：依應用領域分類

  • 藥物測試
  • 研究
  • 移植

第11章：人工器官庫市場：依最終使用者分類

  • 醫院
  • 器官移植中心
  • 研究機構

第12章：人工器官庫市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：人工器官庫市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：人工器官庫市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abiomed, Inc.
  • Artivion, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Berlin Heart GmbH
  • BiVACOR Pty Ltd
  • Boston Scientific Corporation
  • CARMAT SA
  • CELLINK AB
  • Cochlear Limited
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Getinge AB
  • Jarvik Heart, Inc.
  • LivaNova PLC
  • Medtronic plc
  • Miromatrix Medical Inc.
  • Nipro Corporation
  • Organovo Holdings, Inc.
  • OrganOx Limited by Terumo Corporation
  • SynCardia Systems, LLC
  • TransMedics, Inc.
  • Xvivo Perfusion AB
  • Zimmer Biomet Holdings Inc.
Product Code: MRR-43690106585F

The Artificial Organ Bank Market is projected to grow by USD 19.92 billion at a CAGR of 7.25% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 12.20 billion
Estimated Year [2026] USD 13.04 billion
Forecast Year [2032] USD 19.92 billion
CAGR (%) 7.25%

Artificial Organ Bank Executive Summary

An artificial organ bank is emerging as a strategic healthcare infrastructure model that connects artificial organs, bioartificial organs, implantable devices, engineered tissues, organ preservation systems, and digital matching platforms into a more reliable transplant and organ replacement pathway. Demand is grounded in a measurable public health gap: the U.S. Health Resources & Services Administration reports more than 100,000 people on the national transplant waiting list and about 17 deaths each day while waiting for an organ. Similar pressures are amplified globally by aging populations, diabetes, cardiovascular disease, liver disease, respiratory failure, and chronic kidney disease.

The opportunity is not limited to one device category. It spans total artificial hearts, ventricular assist devices, artificial kidney concepts, artificial pancreas systems, bioengineered grafts, regenerative medicine, 3D bioprinting, xenotransplantation research, cryopreservation, machine perfusion, and AI-enabled logistics. As transplant systems move from scarcity management toward precision allocation and manufactured organ substitutes, the artificial organ bank becomes a core platform for resilience, equity, and clinical continuity.

Transformative Shifts in the Artificial Organ Bank Landscape

The artificial organ bank landscape is shifting from experimental innovation to integrated clinical infrastructure. Advances in biomaterials, decellularized scaffolds, stem-cell-derived tissues, organ-on-chip validation, immunomodulation, and additive manufacturing are accelerating the movement from passive storage toward living, monitored, and quality-controlled organ replacement ecosystems. At the same time, hypothermic and normothermic machine perfusion are extending assessment windows for donor organs and shaping quality protocols that are directly relevant to future artificial and bioartificial organ inventories.

Regulation is also reshaping commercialization. The U.S. FDA, European Medicines Agency, EU Medical Device Regulation, and national health technology assessment bodies increasingly require strong evidence on safety, durability, biocompatibility, cybersecurity, sterility assurance, and real-world performance. This raises development complexity but improves clinical credibility, creating an advantage for organizations that combine clinical validation, traceable supply chains, interoperable data systems, and post-market evidence generation.

Cumulative Impact of Artificial Intelligence on Artificial Organ Banking

Artificial intelligence is becoming a cumulative force across artificial organ banking by improving patient-device matching, transplant prioritization, inventory planning, post-implant monitoring, quality assurance, and adverse-event detection. The FDA has authorized hundreds of AI-enabled medical devices across healthcare, demonstrating regulatory momentum for software-driven clinical decision support, although artificial organ applications still require rigorous validation, bias monitoring, cybersecurity controls, and human clinical oversight.

In practice, AI can help integrate imaging, blood type, HLA data, comorbidity profiles, device performance telemetry, preservation metrics, infection-risk indicators, and logistics constraints into more precise allocation and maintenance decisions. The highest-value use cases are not replacing clinicians but reducing avoidable delays, flagging device deterioration, predicting demand by geography, supporting digital twins for personalized organ replacement planning, and strengthening long-term surveillance after implantation.

Key Regional Insights for Artificial Organ Bank Adoption

Asia-Pacific is gaining momentum through large patient populations, rising chronic disease prevalence, expanding transplant centers, and government support for biotechnology in China, Japan, India, South Korea, Australia, and ASEAN economies. The region is also supported by strong electronics, robotics, biomaterials, and regenerative medicine capabilities, although affordability, reimbursement variation, and access gaps remain important barriers. North America remains the most mature innovation hub because of advanced transplant networks, established organ procurement systems, FDA pathways, academic medical centers, reimbursement depth, and active medtech financing. Europe benefits from coordinated transplant organizations, strong biomedical engineering, established tissue and cell governance, and the EU regulatory push toward traceability, safety, and lifecycle monitoring.

Latin America is led by improving transplant capacity in Brazil, Mexico, Argentina, Chile, and Colombia, but access remains uneven across public and private systems, and specialized infrastructure is concentrated in major cities. The Middle East is investing in specialty hospitals, medical tourism, and national transplant programs, especially across GCC economies, where diabetes, cardiovascular disease, and kidney disease create a strong clinical rationale for advanced organ replacement technologies. Africa continues to face infrastructure, specialist workforce, and affordability constraints, yet selected urban centers in South Africa, Egypt, Kenya, and Nigeria are building clinical capabilities that could support future artificial organ bank partnerships, regional training models, and referral-based implant programs.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN presents an important access opportunity as Indonesia, Thailand, Malaysia, Singapore, Vietnam, and the Philippines expand specialist care, transplant services, and private hospital networks, though reimbursement diversity and uneven transplant infrastructure require localized entry models. The GCC is positioned for premium artificial organ and advanced implant adoption because of high healthcare spending, diabetes and cardiovascular disease burden, government-led hospital modernization, and growing emphasis on medical self-sufficiency. The European Union offers scale through harmonized safety expectations, MDR compliance, cross-border research funding, tissue and cell governance, and data protection requirements that encourage traceable, evidence-led artificial organ bank models.

BRICS economies provide volume-driven demand, domestic manufacturing ambitions, and significant chronic disease burdens, making them central to future affordability and localization strategies across artificial organs, preservation systems, and bioengineered tissues. G7 countries remain primary centers for clinical trials, reimbursement innovation, regulatory science, transplant research, and advanced device adoption due to mature healthcare infrastructure and strong academic networks. NATO markets overlap with many high-income health systems and create opportunities for resilient medical supply chains, dual-use logistics, emergency preparedness planning, and standardized procurement frameworks for high-acuity organ replacement technologies.

Key Country Insights for Artificial Organ Bank Market Prioritization

The United States anchors demand with the world's most visible transplant waiting list data, a mature FDA framework, advanced organ procurement networks, and strong adoption of cardiac support, renal support, and diabetes management technologies. Canada emphasizes regulated access, public reimbursement discipline, and specialized transplant centers, while Mexico and Brazil show rising need supported by expanding hospital capacity and chronic disease management programs; Brazil is particularly important because of its large public transplant system and established national organ donation framework. In Latin America, these country-level dynamics point to a pathway where artificial organ bank adoption is likely to begin in advanced tertiary hospitals before expanding through public-private referral networks.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine advanced clinical expertise with rigorous evidence requirements, established transplant networks, and strong medical technology assessment processes, while Spain is globally recognized for organ donation system performance. Russia maintains scientific and clinical capacity but faces procurement, technology access, and geopolitical constraints that can affect advanced implant availability. China and India represent the largest long-term volume opportunities due to population scale, chronic kidney disease, diabetes, cardiovascular disease, and expanding specialty hospital infrastructure, while Japan, South Korea, and Australia offer sophisticated regulatory systems, robotics, regenerative medicine expertise, and high-quality hospital infrastructure for premium artificial organ bank solutions.

Actionable Recommendations for Artificial Organ Bank Leaders

Industry leaders should prioritize clinically validated product portfolios that combine artificial organs, preservation platforms, digital registries, and AI-enabled monitoring rather than standalone devices. Commercial success will depend on proof of survival benefit, quality-of-life improvement, biocompatibility, infection control, device longevity, equitable access, and total cost-of-care reduction.

Organizations should invest early in regulatory strategy, post-market surveillance, cybersecurity, interoperable data architecture, and evidence generation aligned with transplant workflow. Partnerships with transplant centers, payers, tissue banks, bioprinting labs, public health agencies, and logistics providers can accelerate adoption, while regional manufacturing and service hubs can reduce supply risk for high-acuity implants, preservation systems, consumables, and device maintenance.

Research Methodology for Evidence-Based Market Intelligence

This executive summary is developed using a structured secondary research methodology that triangulates public data from health authorities, transplant registries, regulatory agencies, peer-reviewed journals, clinical trial repositories, patent activity, public disclosures, and recognized global health sources. Core reference inputs include HRSA/OPTN, WHO-linked transplant observatories, FDA device databases, EMA and EU regulatory publications, NIH resources, OECD health indicators, and national transplant agencies.

The analysis evaluates demand drivers, technology readiness, clinical adoption barriers, regulatory context, reimbursement feasibility, regional infrastructure, supply chain resilience, and competitive positioning. Insights are validated through cross-source comparison, exclusion of unsupported claims, and emphasis on evidence-based trends rather than speculative market sizing, market share, or forecasting.

Conclusion: Artificial Organ Banks as Next-Generation Healthcare Infrastructure

The artificial organ bank market is moving toward a platform-based future where engineered organs, advanced preservation, AI-enabled matching, and real-world performance data work together to reduce transplant scarcity. The strongest pathways will come from clinically credible technologies that solve measurable capacity gaps while meeting strict safety, durability, cybersecurity, and reimbursement standards.

Organizations that align innovation with transplant workflow, regional access needs, and long-term patient monitoring will be best positioned to lead. As healthcare systems seek alternatives to organ shortages, artificial organ banks can become a defining infrastructure layer for next-generation replacement medicine and a critical bridge between transplantation, regenerative medicine, and intelligent medical device ecosystems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Artificial Organ Bank Market, by Organ Type

  • 7.1. Heart
  • 7.2. Intestine
  • 7.3. Kidney
  • 7.4. Liver
  • 7.5. Lung
  • 7.6. Pancreas

8. Artificial Organ Bank Market, by Technology

  • 8.1. 3D Bioprinting
    • 8.1.1. Extrusion Bioprinting
    • 8.1.2. Inkjet Bioprinting
    • 8.1.3. Laser Assisted Bioprinting
  • 8.2. Cell Culture
  • 8.3. Decellularization
  • 8.4. Scaffold Based Technology
    • 8.4.1. Ceramic Scaffold
    • 8.4.2. Natural Polymer Scaffold
    • 8.4.3. Synthetic Polymer Scaffold

9. Artificial Organ Bank Market, by Material Type

  • 9.1. Biological
    • 9.1.1. Allogenic
    • 9.1.2. Autologous
  • 9.2. Synthetic
    • 9.2.1. Composite
    • 9.2.2. Polymer

10. Artificial Organ Bank Market, by Application

  • 10.1. Pharmaceutical Testing
  • 10.2. Research
  • 10.3. Transplantation

11. Artificial Organ Bank Market, by End User

  • 11.1. Hospitals
  • 11.2. Organ Transplant Centers
  • 11.3. Research Institutes

12. Artificial Organ Bank Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Artificial Organ Bank Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Artificial Organ Bank Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abiomed, Inc.
  • 16.2. Artivion, Inc.
  • 16.3. Asahi Kasei Medical Co., Ltd.
  • 16.4. B. Braun Melsungen AG
  • 16.5. Baxter International Inc.
  • 16.6. Berlin Heart GmbH
  • 16.7. BiVACOR Pty Ltd
  • 16.8. Boston Scientific Corporation
  • 16.9. CARMAT SA
  • 16.10. CELLINK AB
  • 16.11. Cochlear Limited
  • 16.12. CryoLife, Inc.
  • 16.13. Edwards Lifesciences Corporation
  • 16.14. Fresenius Medical Care AG & Co. KGaA
  • 16.15. Getinge AB
  • 16.16. Jarvik Heart, Inc.
  • 16.17. LivaNova PLC
  • 16.18. Medtronic plc
  • 16.19. Miromatrix Medical Inc.
  • 16.20. Nipro Corporation
  • 16.21. Organovo Holdings, Inc.
  • 16.22. OrganOx Limited by Terumo Corporation
  • 16.23. SynCardia Systems, LLC
  • 16.24. TransMedics, Inc.
  • 16.25. Xvivo Perfusion AB
  • 16.26. Zimmer Biomet Holdings Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL ORGAN BANK MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ARTIFICIAL ORGAN BANK MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ARTIFICIAL ORGAN BANK MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ARTIFICIAL ORGAN BANK MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL ORGAN BANK MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ARTIFICIAL ORGAN BANK MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HEART MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HEART MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTESTINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTESTINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTESTINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL KIDNEY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL KIDNEY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL KIDNEY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LIVER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LIVER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LIVER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LUNG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LUNG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LUNG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PANCREAS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PANCREAS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PANCREAS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL 3D BIOPRINTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL 3D BIOPRINTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL EXTRUSION BIOPRINTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL EXTRUSION BIOPRINTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXTRUSION BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INKJET BIOPRINTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INKJET BIOPRINTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INKJET BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LASER ASSISTED BIOPRINTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LASER ASSISTED BIOPRINTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LASER ASSISTED BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CELL CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DECELLULARIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DECELLULARIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DECELLULARIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SCAFFOLD BASED TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SCAFFOLD BASED TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SCAFFOLD BASED TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CERAMIC SCAFFOLD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CERAMIC SCAFFOLD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CERAMIC SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NATURAL POLYMER SCAFFOLD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NATURAL POLYMER SCAFFOLD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NATURAL POLYMER SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SYNTHETIC POLYMER SCAFFOLD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SYNTHETIC POLYMER SCAFFOLD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SYNTHETIC POLYMER SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOLOGICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOLOGICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOLOGICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ALLOGENIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ALLOGENIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ALLOGENIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AUTOLOGOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AUTOLOGOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AUTOLOGOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SYNTHETIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SYNTHETIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SYNTHETIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL COMPOSITE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL COMPOSITE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL COMPOSITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL POLYMER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL POLYMER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL POLYMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL TRANSPLANTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ORGAN TRANSPLANT CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ORGAN TRANSPLANT CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ORGAN TRANSPLANT CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 167. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 170. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 171. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 197. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 200. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 201. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 204. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 207. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 210. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 211. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 225. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 228. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 231. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 232. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 235. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 238. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 241. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 242. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 248. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 249. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 251. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 252. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 265. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 268. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 269. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 271. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 272. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 277. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 278. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 279. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 281. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 282. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 283. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 285. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 287. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 288. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 291. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 292. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 293. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 294. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 295. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 297. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 298. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 299. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 301. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 302. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 303. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 304. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 305. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 307. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 308. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 309. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 311. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 312. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 313. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 314. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 315. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 317. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 318. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 319. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 324. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 325. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 327. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 328. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 329. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 331. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 332. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 333. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 334. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 335. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 336. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 337. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 338. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 339. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 340. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 341. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 342. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 343. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 344. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 345. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 346. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 347. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 348. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 349. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 350. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 351. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 352. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 353. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 354. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 355. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2018-2032 (USD MILLION)
  • TABLE 356. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 357. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2018-2032 (USD MILLION)
  • TABLE 358. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 359. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 360. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 361. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 362. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2018-2032 (USD